AI and digital tools streamline biomedical discovery and diagnostics. A machine learning model, AlphaCD, was developed to precisely characterize over 21,000 cytidine deaminases, accelerating protein functional annotation. Another study employs digital pathology to dissect spatial TGF/BMP signaling in pancreatic cancer, revealing molecular subtypes within tumors. Such advancements enhance precision in research and potential patient stratification.